Skip to main content

Myovant Sciences — Deal History & Benchmarks

Total Deals
3
Across 2 therapeutic areas
Total Deal Value
$18.8B
Cumulative transaction value
Most Active Year
2021
2 deals closed
Primary TA
Women's Health
67% of deal activity

Market Analysis

Myovant Sciences has been involved in 3 transactions totaling $18.8B across Women's Health, Oncology. As a licensor (out-licensor), they have demonstrated an active acquisition strategy.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Myovant Sciences done?
Myovant Sciences has completed 3 verified transactions tracked in our database, spanning from 2021 to 2022. These deals have a combined value of $18.8B.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating